|
Clerk of the House of Representatives Legislative Resource Center 135 Cannon Building Washington, DC 20515 http://lobbyingdisclosure.house.gov |
Secretary of the Senate Office of Public Records 232 Hart Building Washington, DC 20510 http://www.senate.gov/lobby |
LOBBYING REGISTRATION
Lobbying Disclosure Act of 1995 (Section 4)
| 1. Effective Date of Registration | 07/01/2013 |
||||
| 2. House Identification | 36548 |
Senate Identification | 86196 |
||
REGISTRANT Organization/Lobbying Firm Self Employed Individual
| 3. Registrant | Organization | The Glover Park Group LLC |
||||
| Address | 1025 F Street NW |
Address2 | 9th Floor |
| City | Washington |
State | DC |
Zip | 20004 |
Country | USA |
4. Principal place of business (if different than line 3)
| City | |
State | |
Zip | |
Country | |
| 5. Contact name and telephone number | International Number |
| Contact | Mr. Joel Johnson |
Telephone | 2023370808 |
jjohnson@gloverparkgroup.com |
CLIENT A Lobbying Firm is required to file a separate registration for each client. Organizations employing in-house lobbyists should check the box labeled “Self” and proceed to line 10. Self
| 7. Client name | Inspirion Delivery Technologies, LLC |
| Address | 90 Washington Valley Rd. |
| City | Bedminster |
State | NJ |
Zip | 07921 |
Country | USA |
| City | |
State | |
Zip | |
Country | |
LOBBYISTS
10. Name of each individual who has acted or is expected to act as a lobbyist for the client identified on line 7. If any person listed in this section has served as a “covered executive branch official” or “covered legislative branch official” within twenty years of first acting as a lobbyist for the client, state the executive and/or legislative position(s) in which the person served.
| Name | Covered Official Position (if applicable) | ||
First |
Last |
Suffix |
|
| Elizabeth | Engel | | Deputy Assistant Secretary for Legislation, |
| Elizabeth | Engel | | Mandatory Health Programs, Dep. of HHS |
| Elizabeth | Engel | | Health Policy Advisor, U.S. Senate Democratic |
| Elizabeth | Engel | | Policy Committee |
| Elizabeth | Engel | | Legislative Assistant, Rep. Richard Lehman |
LOBBYING ISSUES
11. General lobbying issue areas (Select all applicable codes).
HCR |
|
|
|
|
|
|
|
|
12. Specific lobbying issues (current and anticipated)
Lobbying related to prescription drug abuse.
AFFILIATED ORGANIZATIONS
13. Is there an entity other than the client that contributes more than $5,000 to the lobbying activities of the registrant in a quarterly period and either participates in and/or in whole or in major part supervises or controls the registrant’s lobbying activities?
| No --> Go to line 14. | Yes --> Complete the rest of this section for each entity matching the criteria above, then proceed to line 14. |
| Internet Address: | |
| Name | Address | Principal Place of Business | ||||||||
| Street | ||||||||||
|
||||||||||
Epax US Holdings Corp. |
c/o Trygg Pharma Group, Mundkedamsveien 35 |
|
||||||||
|
|
|||||||||
Epax US LLC |
c/o Trygg Phrma Group, Mundkedamsveien 35 |
|
||||||||
|
|
|||||||||
|
|
|
||||||||
|
|
FOREIGN ENTITIES
14. Is there any foreign entity
a) holds at least 20% equitable ownership in the client or any organization identified on line 13; or
b) directly or indirectly, in whole or in major part, plans, supervises, controls, directs, finances or subsidizes activities of the client or any organization identified on line 13; or
c) is an affiliate of the client or any organization identified on line 13 and has a direct interest in the outcome of the lobbying activity?
| No --> Sign and date the registration. | Yes --> Complete the rest of this section for each entity matching the criteria above, then sign the registration. |
| Address | Ownership | |||||
| Name | Street | Principal place of business | Amount of contribution | |||
|
(city and state or country) | for lobbying activities | ||||
Mundkedamsveien 35 |
|
|||||||||||
Trygg Pharma Group |
|
|
0.00 |
0 |
% | |||||||
Fjordalleen 16 |
|
|||||||||||
Aker Bio Marine |
|
|
0.00 |
0 |
% |
| Signature | Digitally Signed By: Joel Johnson, Managing Director |
Date | 12/31/2013 |
10. Supplemental. List any additional lobbyists for this client not listed on page 1, number 10.
| Name | Covered Official Position (if applicable) | Have you been convicted of a crime? | ||
First |
Last |
Suffix |
||
| Elizabeth | Engel | | Staff Assistant/Press Assistant, Senator | |
| Elizabeth | Engel | | Barbara Boxer | |
| John | Myers | | Staff Assistant, Sen. Arlen Specter | |
| John | Myers | | Legislative Correspondent, Sen. Arlen Specter | |
| John | Myers | | Legislative Aide, Sen. Arlen Specter | |
| John | Myers | | Legislative Assistant, Sen. Arlen Specter | |
|
|
|
|
|
|
|
|
|
| Name | Address | Principal Place of Business | ||||||||
| Street | ||||||||||
|
||||||||||
|
|
|
||||||||
|
|
|||||||||
|
|
|
||||||||
|
|
|||||||||
|
|
|
||||||||
|
|
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership | ||||||||||||||
| ||||||||||||||||||
Pharmnutra Holdings II BV |
|
|
0.00 |
0 % |
||||||||||||||
Epax US Holdings Corp.
(c/o Trygg Pharma Group) |
|
|
0.00 |
0 % |
||||||||||||||
Epax US LLC
(c/o Trygg Pharma Group) |
|
|
0.00 |
0 % |
||||||||||||||
10. Supplemental. List any additional lobbyists for this client not listed on page 1, number 10.
| Name | Covered Official Position (if applicable) | Have you been convicted of a crime? | ||
First |
Last |
Suffix |
||
| John | Myers | | Sr. Health and Science Policy Advisor, | |
| John | Myers | | Sen. Arlen Specter | |
| Brian | Gaston | | Member Services Director, Republican | |
| Brian | Gaston | | Conference Committee, Chairman Dick Armey | |
| Brian | Gaston | | Republican Conference Committee Chairman | |
| Brian | Gaston | | John Boehner | |
|
|
|
|
|
|
|
|
|
| Name | Address | Principal Place of Business | ||||||||
| Street | ||||||||||
|
||||||||||
|
|
|
||||||||
|
|
|||||||||
|
|
|
||||||||
|
|
|||||||||
|
|
|
||||||||
|
|
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership | ||||||||||||||
| ||||||||||||||||||
|
|
|
|
% |
||||||||||||||
|
|
|
|
% |
||||||||||||||
|
|
|
|
% |
||||||||||||||
10. Supplemental. List any additional lobbyists for this client not listed on page 1, number 10.
| Name | Covered Official Position (if applicable) | Have you been convicted of a crime? | ||
First |
Last |
Suffix |
||
| Brian | Gaston | | Policy Director, House Maj. Leader Dick Armey | |
| Brian | Gaston | | Policy Director, House Maj.Whip Roy Blunt | |
| Brian | Gaston | | Chief of Staff, House Majority Whip Roy Blunt | |
| Brian | Gaston | | Leadership Advisor, Rep. Roy Blunt | |
| | | | | |
| | | | | |
|
|
|
|
|
|
|
|
|
| Name | Address | Principal Place of Business | ||||||||
| Street | ||||||||||
|
||||||||||
|
|
|
||||||||
|
|
|||||||||
|
|
|
||||||||
|
|
|||||||||
|
|
|
||||||||
|
|
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership | ||||||||||||||
| ||||||||||||||||||
|
|
|
|
% |
||||||||||||||
|
|
|
|
% |
||||||||||||||
|
|
|
|
% |
||||||||||||||